STOCK TITAN

Alcon Inc. - ALC STOCK NEWS

Welcome to our dedicated news page for Alcon (Ticker: ALC), a resource for investors and traders seeking the latest updates and insights on Alcon.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Alcon's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Alcon's position in the market.

Rhea-AI Summary
Alcon (SIX/NYSE: ALC) announced the global launch of TOTAL30® Multifocal, the first and only monthly Water Gradient multifocal contact lens. The lenses provide excellent visual acuity at all distances, addressing the vision and comfort needs of the global multifocal market, a rapidly growing market valued over $1 billion globally and growing double digit annually. The lenses have begun to roll out in the United States and select international markets, offering Alcon's premium Water Gradient innovation at a more accessible price point of monthly lenses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
none
-
Rhea-AI Summary
Alcon's Vivity Registry Study demonstrates excellent outcomes with AcrySof IQ Vivity and AcrySof IQ Vivity Toric
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Alcon presents scientific data and innovations at the 41st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). Alcon's intraocular lens and surgical equipment portfolio showcased, including the next generation in refractive surgery. Alcon expands Global Medical Affairs website to support eye care professionals in multiple countries. Alcon to host symposia and booth talks on various topics related to cataract surgery. Alcon sponsors ESCRS iNovation Day and near-live surgery sessions. Alcon emphasizes commitment to sustainability. Please refer to relevant products DFU or Operator’s manuals for complete list of indications, contraindications, and warnings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
none
Rhea-AI Summary
Alcon, the global leader in eye care, reported sales of $2.4 billion in Q2 2023, a 9% increase compared to the previous year. Diluted EPS was $0.34, up 13%. The company raised its full-year 2023 sales and core diluted EPS guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.02%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.52%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
none
Alcon Inc.

NYSE:ALC

ALC Rankings

ALC Stock Data

39.45B
492.28M
0.14%
66.11%
0.88%
Ophthalmic Goods Manufacturing
Manufacturing
Link
Switzerland
Vernier

About ALC

Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.